Platforms for biomarker analysis using high-throughput approaches in genomics, transcriptomics, proteomics, metabolomics, and bioinformatics - PubMed

Affiliations

• PMID: 22997859

Review

Platforms for biomarker analysis using high-throughput approaches in genomics, transcriptomics, proteomics, metabolomics, and bioinformatics

B Alex Merrick et al. IARC Sci Publ. 2011.

Abstract

Global biological responses that reflect disease or exposure biology are kinetic and highly dynamic phenomena. While high-throughput DNA sequencing continues to drive genomics, the possibility of more broadly measuring changes in gene expression has been a recent development manifested by a diversity of technical platforms. Such technologies measure transcripts, proteins and small biological molecules, or metabolites, and respectively define the fields of transcriptomics, proteomics and metabolomics that can be performed at a cell-, tissue-, or organism-wide basis. Bioinformatics is the discipline that derives knowledge from the large quantity and diversity of biological, genetic, genomic and gene expression data by integrating computer science, mathematics, statistics and graphic arts. Gene, protein and metabolite expression profiles can be thought of as snapshots of the current, poorly-mapped molecular landscape. The ultimate aim of genomic platforms is to fully map this landscape to more completely describe all of the biological interactions within a living system, during disease and toxicity, and define the behaviour and relationships of all the components of a biological system. The development of databases and knowledge bases will support the integration of data from multiple domains, as well as computational modelling. This chapter will describe the technical platform methods involving DNA sequencing, mass spectrometry, nuclear magnetic resonance combined with separation systems, and bioinformatics to derive genomic and gene expression data and include the relevant bioinformatic tools for analysis. These genomic, or omics platforms should have wide application to epidemiological studies.

Similar articles

• Where are we in genomics?

  Hocquette JF. Hocquette JF. J Physiol Pharmacol. 2005 Jun;56 Suppl 3:37-70. J Physiol Pharmacol. 2005. PMID: 16077195 Review.

• Functional genomics and proteomics in the clinical neurosciences: data mining and bioinformatics.

  Phan JH, Quo CF, Wang MD. Phan JH, et al. Prog Brain Res. 2006;158:83-108. doi: 10.1016/S0079-6123(06)58004-5. Prog Brain Res. 2006. PMID: 17027692 Review.

• Bioinformatics meets parasitology.

  Cantacessi C, Campbell BE, Jex AR, Young ND, Hall RS, Ranganathan S, Gasser RB. Cantacessi C, et al. Parasite Immunol. 2012 May;34(5):265-75. doi: 10.1111/j.1365-3024.2011.01304.x. Parasite Immunol. 2012. PMID: 21615422 Review.

• "Omics" in pharmaceutical research: overview, applications, challenges, and future perspectives.

  Yan SK, Liu RH, Jin HZ, Liu XR, Ye J, Shan L, Zhang WD. Yan SK, et al. Chin J Nat Med. 2015 Jan;13(1):3-21. doi: 10.1016/S1875-5364(15)60002-4. Chin J Nat Med. 2015. PMID: 25660284 Review.

• Community-acquired pneumonia: genomics, epigenomics, transcriptomics, proteomics, and metabolomics.

  Waterer GW. Waterer GW. Semin Respir Crit Care Med. 2012 Jun;33(3):257-65. doi: 10.1055/s-0032-1315637. Epub 2012 Jun 20. Semin Respir Crit Care Med. 2012. PMID: 22718211 Review.

Cited by

• Omics-Based Investigations of Breast Cancer.

  Neagu AN, Whitham D, Bruno P, Morrissiey H, Darie CA, Darie CC. Neagu AN, et al. Molecules. 2023 Jun 14;28(12):4768. doi: 10.3390/molecules28124768. Molecules. 2023. PMID: 37375323 Free PMC article. Review.

• Identification and validation of novel biomarker TRIM8 related to cervical cancer.

  Zhang L, Dan Y, Ou C, Qian H, Yin Y, Tang M, He Q, Peng C, He A. Zhang L, et al. Front Oncol. 2022 Oct 24;12:1002040. doi: 10.3389/fonc.2022.1002040. eCollection 2022. Front Oncol. 2022. PMID: 36353542 Free PMC article.

• Hair metabolomics: identification of fetal compromise provides proof of concept for biomarker discovery.

  Sulek K, Han TL, Villas-Boas SG, Wishart DS, Soh SE, Kwek K, Gluckman PD, Chong YS, Kenny LC, Baker PN. Sulek K, et al. Theranostics. 2014 Jul 20;4(9):953-9. doi: 10.7150/thno.9265. eCollection 2014. Theranostics. 2014. PMID: 25057319 Free PMC article.

• Overexpression of BUB1B, CCNA2, CDC20, and CDK1 in tumor tissues predicts poor survival in pancreatic ductal adenocarcinoma.

  Dong S, Huang F, Zhang H, Chen Q. Dong S, et al. Biosci Rep. 2019 Feb 26;39(2):BSR20182306. doi: 10.1042/BSR20182306. Print 2019 Feb 28. Biosci Rep. 2019. PMID: 30765611 Free PMC article.

• Comparative Metabolomics and Transcriptome Studies of Two Forms of Rhododendron chrysanthum Pall. under UV-B Stress.

  Yu W, Gong F, Zhou X, Xu H, Lyu J, Zhou X. Yu W, et al. Biology (Basel). 2024 Mar 24;13(4):211. doi: 10.3390/biology13040211. Biology (Basel). 2024. PMID: 38666823 Free PMC article.

Publication types

MeSH terms

Substances